MDLN Medline sharp Q4 2025 EPS miss triggers investor selloff pushing shares down 318 today What top holdings OnKure Therapeutics OKUR Smart Money Active 20260427 US Press Freedom and Public Sector Governance Risk Analysis Biogen Inc BIIB Dual Wall Street Upgrades Signal Bullish Pipeline Catalyst Upside BATRK ATL Braves stock climbs 279 percent despite Q4 2025 EPS miss that fell short of analyst estimates